Evidence map›Paper›PMID 37718909›Full record

ArticleDisease models & mechanisms2023

Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice.

Jie Gao, Shumei Ren, Gabrielle Choonoo, Guoying Chen, Davor Frleta, Jun Zhong, Namita Gupta, Prachi Sharma, Adelekan Oyejide, Gurinder S Atwal and 3 more

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. "Next top" mouse models advancing CTCL research.Frontiers in cell and developmental biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Jie GaoRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Shumei RenRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Gabrielle ChoonooRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.ORCID 0000-0001-6856-5006
Guoying ChenRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Davor FrletaRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Jun ZhongRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Namita GuptaRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.ORCID 0000-0002-4517-1546
Prachi SharmaRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Adelekan OyejideRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Gurinder S AtwalRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.ORCID 0000-0002-0125-6943
Lynn MacdonaldRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Andrew MurphyRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Frank KuhnertRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.ORCID 0000-0003-4603-4225
Regeneron (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sezary syndrome (SS) is a rare, aggressive leukemic variant of cutaneous T-cell lymphoma (CTCL) that lacks adequate therapeutic options and representative small-animal models. Here, we demonstrate that IL-15 is a critical CTCL growth factor. Importantly, an immunodeficient knock-in mouse model genetically engineered to express human IL-15 uniquely supported the growth of SS patient samples relative to conventional immunodeficient mouse strains. SS patient-derived xenograft (PDX) models recapacitated key pathological features of the human disease, including skin infiltration and spread of leukemic cells to the periphery, and maintained the dependence on human IL-15 upon serial in vivo passaging. Detailed molecular characterization of the engrafted cells by single-cell transcriptomic analysis revealed congruent neoplastic gene expression signatures but distinct clonal engraftment patterns. Overall, we document an important dependence of Sezary cell survival and proliferation on IL-15 signaling and the utility of immunodeficient humanized IL-15 mice as hosts for SS - and potentially other T and NK cell-derived hematologic malignancies - PDX model generation. Furthermore, these studies advocate the thorough molecular understanding of the resultant PDX models to maximize their translational impact.

Indexed as

Lymphoma, T-Cell, CutaneousSezary SyndromeSkin NeoplasmsAnimalsHumansInterleukin-15LymphocytesMiceTumor MicroenvironmentInterleukin-15CTCLHumanized miceIL-15PDXSezary syndrome

Identifiers

PMID37718909
PMCPMC10581384
OpenAlexW4386817423

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.